71.02 0.00 (0.00%)
After hours: 4:16PM EDT
|Bid||71.01 x 900|
|Ask||71.05 x 800|
|Day's Range||70.97 - 72.00|
|52 Week Range||56.96 - 92.59|
|Beta (3Y Monthly)||1.49|
|PE Ratio (TTM)||62.41|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
How far off is Omnicell, Inc. (NASDAQ:OMCL) from its intrinsic value? Using the most recent financial data, we'll take...
Omnicell (OMCL) delivered earnings and revenue surprises of 4.69% and 1.98%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Omnicell (OMCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Shares of Omnicell rebounded Monday after the automated pharmacy company refuted claims from short-seller GlassHouse Research that it prematurely recognized $38.3 million in revenue.
Omnicell tumbled Thursday after a short-seller accused the automated pharmacy company of "accounting gimmicks," including prematurely recording revenue and not writing off legacy inventory.
Short seller GlassHouse Research has chosen Omnicell, Inc. (NASDAQ: OMCL) as its latest target, accusing the company of deceptive financial practices. GlassHouse alleges Onicell has prematurely recorded revenues and intentionally failed to not write-off its legacy inventory, thereby artificially inflating its balance sheet. In fact, Glasshouse said Omnicell has one of the worst accounts receivable positions the firm has ever seen in a public company.
Does Omnicell, Inc. (NASDAQ:OMCL) represent a good buying opportunity at the moment? Let’s quickly check the hedge fund interest towards the company. Hedge fund firms constantly search out bright intellectuals and highly-experienced employees and throw away millions of dollars on satellite photos and other research activities, so it is no wonder why they tend to […]
When you buy a stock there is always a possibility that it could drop 100%. But on the bright side, if you buy shares...
Omnicell (OMCL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.